Regal Investment Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Regal Investment Advisors LLC

$1.49 Billion
Q2 2024

A detailed history of Regal Investment Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Regal Investment Advisors LLC holds 2,056 shares of VRTX stock, worth $1.03 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,056

Previous 1,983 3.68%

Holding current value

$1.03 Million

Previous $828,000 16.3%

% of portfolio

0.06%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $28,675 - $35,443	73 Added 3.68%	2,056 $963,000
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $20,792 - $22,750	51 Added 2.64%	1,983 $828,000
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $273,371 - $327,311	797 Added 70.22%	1,932 $786,000
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $9,130 - $9,786	-27 Reduced 2.32%	1,135 $394,000
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $45,590 - $51,026	145 Added 14.26%	1,162 $408,000
Q1 2023 May 11, 2023	SELL	$283.23 - $323.1 $1.12 Million - $1.28 Million	-3,970 Reduced 79.61%	1,017 $320,000
Q4 2022 Mar 01, 2023	SELL	$285.76 - $321.48 $201,175 - $226,321	-704 Reduced 12.37%	4,987 $1.44 Million
Q3 2022 Nov 15, 2022	BUY	$273.83 - $305.53 $126,509 - $141,154	462 Added 8.84%	5,691 $1.65 Million
Q2 2022 Aug 09, 2022	BUY	$234.96 - $292.55 $532,889 - $663,503	2,268 Added 76.6%	5,229 $1.47 Million
Q1 2022 May 09, 2022	BUY	$221.42 - $260.97 $239,797 - $282,630	1,083 Added 57.67%	2,961 $773,000
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $3,009 - $3,798	17 Added 0.91%	1,878 $412,000
Q3 2021 Nov 05, 2021	BUY	$181.39 - $202.99 $31,199 - $34,914	172 Added 10.18%	1,861 $338,000
Q2 2021 Aug 09, 2021	BUY	$187.49 - $221.1 $316,670 - $373,437	1,689 New	1,689 $341,000
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $217,578 - $253,616	-1,051 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $217,567 - $290,170	1,051 New	1,051 $248,000
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $326,976 - $387,664	-1,279 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$225.48 - $295.8 $288,388 - $378,328	1,279 New	1,279 $371,000
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $320,031 - $396,991	-1,602 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$166.71 - $223.91 $267,069 - $358,703	1,602 New	1,602 $351,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.

Account

Regal Investment Advisors LLC Vertex Pharmaceuticals Inc Transaction History